Elevance Health is riding high after a strong Q3, posting $1.4 billion in profit and topping analyst expectations on both revenue and earnings. The insurer raised its full-year earnings guidance and credited improved medical cost management across Medicare Advantage and the individual market. It also tapped Jeff Park as the new president of its Carelon health services unit.
Elevance Health had a strong third quarter, reporting $1.4 billion in profit — up from $1.2 billion in Q3 2025 — and beating Wall Street expectations on both the top and bottom lines. Revenues came in at $50.4 billion for the quarter, roughly flat year-over-year, while nine-month revenues climbed to $149.8 billion. CEO Gail Boudreaux credited "stronger execution across our diversified portfolio" and pointed to the combined strength of its Health Benefits business and Carelon services unit.
A key bright spot: the company's medical loss ratio improved to 90.6% from 91.7% a year ago, signaling better control over healthcare costs — particularly in Medicare Advantage and the individual market, two segments that have been under intense pressure industry-wide. Membership did dip by about 487,000 year-over-year to 44.9 million, reflecting declines across MA, Medicaid, and employer group plans.
By the Numbers:
Why it matters: Elevance's results offer a window into the financial health of one of the nation's largest insurers — and suggest the industry may be turning a corner on medical cost pressures that weighed heavily on earnings throughout 2024 and 2025. The raised guidance and leadership changes at Carelon signal confidence in continued growth heading into 2027.
